The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia

Adductor Spasmodic Dysphonia Clinical Trial

Official title:
The Effect of Vocal Rest Versus Vocalization Following Xeomin® Injections in Spasmodic Dysphonia

Status Enrolling by invitation

Clinical Trial Summary

This study will compare the effects of vocal rest versus continuous vocalization for one hour immediately following botulinum toxin injections for adductor spasmodic dysphonia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03129087
Study type	Interventional
Source	Lawson Health Research Institute
Contact
Status	Enrolling by invitation
Phase	N/A
Start date	May 23, 2017
Completion date	May 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05158166` - DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia	Phase 1/Phase 2
Not yet recruiting	`NCT06402214` - The 'Lombard Effect' in Patients Affected by Adductor Laryngeal Dystonia	N/A
Completed	`NCT03349086` - Effects of Vocal Exercises for Spasmodic Dysphonia	N/A
Completed	`NCT02528006` - Treatment for Adductor Spasmodic Dysphonia by Type 2 Thyroplasty Using Titanium Bridges	Phase 2/Phase 3
Not yet recruiting	`NCT05467228` - Laryngeal Vibro-tactile Stimulation as a Non-invasive Symptomatic Treatment for Spasmodic Dysphonia	Phase 2
Completed	`NCT05158179` - Assessment of Laryngopharyngeal Sensation in Adductor Spasmodic Dysphonia	N/A